https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45660 Wed 02 Nov 2022 15:52:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32783 Low-polydrug (n = 491), (2) Opiates-polydrug (n = 123), and (3) Alcohol-polydrug (n = 213). There was a trend for the Low-polydrug class to demonstrate better functioning and safer injecting practices than the Opiates-polydrug and Alcohol-polydrug classes. Conclusion: The results suggest that the majority of people accessing treatment who inject amphetamine as their primary drug of choice have a low probability of heroin or other opiate use. It is important that future research consider whether traditional harm minimisation strategies are appropriate for people who primarily inject amphetamine.]]> Thu 17 Feb 2022 09:25:00 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49312 Thu 11 May 2023 14:39:06 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47974 Mon 13 Feb 2023 16:19:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41261 Mon 01 Aug 2022 09:21:36 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47446 Fri 20 Jan 2023 14:15:24 AEDT ]]>